Biological Safety Testing Market By Product Type, By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Adventitious Agent Detection ...
Biological Safety Testing Industry Outlook: From US$ 4.1 Billion in 2021 to US$ 10.8 Billion by 2030
The global biological safety testing market size was US$ 4.1 billion in 2021. The global biological safety testing market is forecast to grow to US$ 10.8 billion by 2030 by registering a compound ...
(MENAFN- Quintile Reports) The Global Biological Safety Testing Products and Services Market was estimated at USD 5.38 billion in 2025 and is projected to reach USD 15.03 billion by 2035, growing at a ...
Bionique Testing Laboratories (Bionique), a subsidiary of Asahi Kasei and a globally recognized specialist in mycoplasma and ...
MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, has opened its new $286 million biosafety testing facility in Rockville. Biosafety testing and analytical ...
Facility consolidates biosafety testing, analytical development, and cell bank manufacturing services into single building New rapid test offering with Blazar ® CHO Animal Origin Free (AOF) delivers ...
DUBLIN--(BUSINESS WIRE)--The "Biologics Development and Manufacturing Testing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide ...
Biosafety cabinets protect laboratory personnel and the environment from harmful contaminants, requiring accreditation ...
MilliporeSigma, the life science business of Germany-based Merck KGaA, reports that it is investing €35 million ($37 million) in biosafety testing at its Glasgow and Stirling sites in Scotland. The ...
MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Germany, says it has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra™ CHO genetic ...
Management team: Paula MacDonald, the CEO and co-founder, has more than 25 years’ experience in the biomedical sector. She previously served as CEO of Accugenix. She was also executive director of ...
Facility consolidates biosafety testing, analytical development, and cell bank manufacturing services into single building New rapid test offering with Blazar ® CHO Animal Origin Free (AOF) delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results